3 active not recruiting, 2 completed, 1 not yet recruiting, 1 unknown. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Active not recruiting 3, Completed 2, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow HPV InfectioN: new trials by email Literature Review of HPV InfectioN trials Research Report on HPV InfectioN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）, placebo - HPV InfectioN, HPV-Related Carcinoma | Phase 3 | Active not recruiting | Sinocelltech Ltd. | 18000 | 2023-08-13 | 2023-09-18 |
| Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial HPV vaccine, HPV testing, HAV vaccine - HPV Infection | Phase 3 | Not yet recruiting | International Agency for Research on Cancer | 8000 | 2023-02-01 | 2022-08-03 |
| A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 18-45 Years 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), placebo - HPV InfectioN, HPV-Related Carcinoma | Phase 3 | Active not recruiting | National Vaccine and Serum Institute, China | 13500 | 2022-06-04 | 2026-10-28 |
| Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris) - HPV Infection | Phase 3 | Completed | Shanghai Zerun Biotechnology Co.,Ltd | 1100 | 2021-04-20 | 2023-04-13 |
| Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58), Saline Placebo - HPV Positive Oropharyngeal Squamous Cell Carcinoma, HIV-1-infection | Phase 3 | Active not recruiting | Weill Medical College of Cornell University | 700 | 2021-02-23 | 2026-09-14 |
| The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa" HPV DNA Test, VIA triage test, Treatment by ablative treatment - HPV Infection | Phase 3 | Unknown | International Agency for Research on Cancer | 1500 | 2019-10-01 | 2024-03-13 |
| Recombinant Human Interferon a-2b Gel for HPV Gynecological Infections Yallaferon® - HPV Infection | Phase 2 / Phase 3 | Completed | Lee's Pharmaceutical Limited | 325 | 2011-03-01 | 2013-04-05 |
Papillomavirus Infections (7) · HIV Infections (1)
Communicable Diseases (7) · DNA Virus Infections (7) · Disease Attributes (7) · Genital Diseases (7) · Infections (7) · Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Sexually Transmitted Diseases (7) · Sexually Transmitted Diseases, Viral (7) · Tumor Virus Infections (7) · Urogenital Diseases (7) · Virus Diseases (7) · Blood-Borne Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1)
Colposcopy (1) · Human Papillomavirus DNA Tests (1) · Papillomavirus Vaccines (1) · Vaccines (1)
International Agency for Research on Cancer (2) · Lee's Pharmaceutical Limited (1) · National Vaccine and Serum Institute, China (1) · Shanghai Zerun Biotechnology Co.,Ltd (1) · Sinocelltech Ltd. (1) · Weill Medical College of Cornell University (1)
China (3) · Brazil (1) · Mexico (1) · Puerto Rico (1) · Senegal (1) · South Africa (1)
Ting Huang (2) · Ajay Rangaraj, MD, MSc (1) · Armando Baena, MSc, PhD (1) · Florence A Anabwani-Richter, MBChB, MPH (1) · Grant Ellsworth, MD, MS (1) · Guohua Li (1) · Haynes van der Merwe, MD, PhD (1) · Hennie Botha, MD, PhD (1) · Jean-Marie Dangou, PhD (1) · Joan Valls, MSc, PhD (1) · Laura Downham, MSc (1) · Lisbeth Lebelo, PhD (1) · Maribel Almonte, Dr (1) · Maribel Almonte, MPH, MSc, PhD (1) · Marleen Temmerman, MD, PhD (1)
U54CA242639 (1)